Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gen Kanayama, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Steele I, Pope H, Ip EJ, Barnett MJ, Kanayama G. Is competitive body-building pathological? Survey of 984 male strength trainers. BMJ Open Sport Exerc Med. 2020; 6(1):e000708. PMID: 32419952.
    Citations:    
  2. Hudson JI, Kanayama G, Pope HG, Muse S, Kaufman MJ, Baggish A, Waikar SS. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 Jul; 76(1):152-155. PMID: 32362416.
    Citations:    
  3. Kanayama G, Hudson JI, Pope HG. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychother Psychosom. 2020; 89(2):65-73. PMID: 32066136.
    Citations:    
  4. Steele IH, Pope HG, Kanayama G. Competitive Bodybuilding: Fitness, Pathology, or Both? Harv Rev Psychiatry. 2019 Jul/Aug; 27(4):233-240. PMID: 31219882.
    Citations:    
  5. Kaufman MJ, Kanayama G, Hudson JI, Pope HG. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci Biobehav Rev. 2019 05; 100:180-207. PMID: 30817935.
    Citations:    
  6. Kanayama G, Kaufman MJ, Pope HG. Public health impact of androgens. Curr Opin Endocrinol Diabetes Obes. 2018 06; 25(3):218-223. PMID: 29369918.
    Citations:    Fields:    
  7. Kanayama G, Pope HG, Hudson JI. Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs. Psychol Med. 2018 11; 48(15):2601-2608. PMID: 29490719.
    Citations:    Fields:    
  8. Ulrich R, Pope HG, Cléret L, Petróczi A, Nepusz T, Schaffer J, Kanayama G, Comstock RD, Simon P. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys. Sports Med. 2018 01; 48(1):211-219. PMID: 28849386.
    Citations: 6     Fields:    Translation:Humans
  9. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002. PMID: 28533317.
    Citations: 4     Fields:    Translation:Humans
  10. Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018 03 15; 464:4-13. PMID: 28245998.
    Citations:    Fields:    
  11. Seitz J, Lyall AE, Kanayama G, Makris N, Hudson JI, Kubicki M, Pope HG, Kaufman MJ. White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res Neuroimaging. 2017 Feb 28; 260:1-5. PMID: 27988413.
    Citations:    
  12. Kanayama G, DeLuca J, Meehan WP, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44. PMID: 26362436.
    Citations: 6     Fields:    Translation:Humans
  13. Hallgren M, Pope HG, Kanayama G, Hudson JI, Lundin A, Källmén H. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res. 2015; 21(6):321-6. PMID: 26113433.
    Citations: 1     Fields:    Translation:Humans
  14. Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015 Jul 01; 152:47-56. PMID: 25986964.
    Citations: 7     Fields:    Translation:Humans
  15. Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31. PMID: 25598171.
    Citations: 6     Fields:    Translation:Humans
  16. Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7. PMID: 24112239.
    Citations: 22     Fields:    Translation:Humans
  17. Brennan BP, Kanayama G, Pope HG. Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 2013 Mar-Apr; 22(2):158-61. PMID: 23414502.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  18. Kanayama G, Kean J, Hudson JI, Pope HG. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):208-14. PMID: 23253252.
    Citations: 11     Fields:    Translation:Humans
  19. Kersey RD, Elliot DL, Goldberg L, Kanayama G, Leone JE, Pavlovich M, Pope HG. National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train. 2012 Sep-Oct; 47(5):567-88. PMID: 23068595.
    Citations: 8     Fields:    Translation:Humans
  20. Kanayama G, Pope HG. Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes. 2012 Jun; 19(3):211-9. PMID: 22450858.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  21. Kanayama G, Hudson JI, Pope HG. Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom. 2012; 81(2):73-8. PMID: 22261875.
    Citations: 2     Fields:    Translation:Humans
  22. Rothman RD, Weiner RB, Pope H, Kanayama G, Hutter AM, Fifer MA, Dec GW, Baggish AL. Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population. BMJ Case Rep. 2011 Aug 17; 2011. PMID: 22688938.
    Citations: 1     Fields:    Translation:Humans
  23. Pope HG, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Feb 01; 71(3):254-61. PMID: 21839424.
    Citations: 19     Fields:    Translation:Humans
  24. Kanayama G, Pope HG. Gods, men, and muscle dysmorphia. Harv Rev Psychiatry. 2011 Mar-Apr; 19(2):95-8. PMID: 21425938.
    Citations: 2     Fields:    Translation:Humans
  25. Amiaz R, Pope HG, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54. PMID: 21707327.
    Citations: 8     Fields:    Translation:Humans
  26. Brennan BP, Kanayama G, Hudson JI, Pope HG. Human growth hormone abuse in male weightlifters. Am J Addict. 2011 Jan-Feb; 20(1):9-13. PMID: 21175915.
    Citations: 12     Fields:    Translation:Humans
  27. Pope HG, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, Hudson JI. A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol. 2010 Jun; 18(3):203-13. PMID: 20545384.
    Citations: 10     Fields:    Translation:Humans
  28. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Pope HG. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010 Jul; 3(4):472-6. PMID: 20424234.
    Citations: 22     Fields:    Translation:Humans
  29. Pope HG, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010 Apr; 30(2):126-34. PMID: 20520285.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  30. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):6-13. PMID: 20188494.
    Citations: 17     Fields:    Translation:Humans
  31. Grelotti DJ, Kanayama G, Pope HG. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry. 2010 Jan; 167(1):17-23. PMID: 20068123.
    Citations: 18     Fields:    Translation:Humans
  32. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009 Dec; 104(12):1966-78. PMID: 19922565.
    Citations: 38     Fields:    Translation:HumansAnimals
  33. Kanayama G, Hudson JI, Pope HG. Illicit anabolic-androgenic steroid use. Horm Behav. 2010 Jun; 58(1):111-21. PMID: 19769977.
    Citations: 41     Fields:    Translation:HumansAnimals
  34. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009 Jun; 166(6):642-5. PMID: 19487399.
    Citations: 18     Fields:    Translation:Humans
  35. Kanayama G, Hudson JI, Pope HG. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):130-7. PMID: 19339124.
    Citations: 22     Fields:    Translation:Humans
  36. Kanayama G, Hudson JI, Pope HG. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 01; 98(1-2):1-12. PMID: 18599224.
    Citations: 54     Fields:    Translation:Humans
  37. Pillay SS, Rogowska J, Kanayama G, Gruber S, Simpson N, Pope HG, Yurgelun-Todd DA. Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol. 2008 Feb; 16(1):22-32. PMID: 18266549.
    Citations: 12     Fields:    Translation:Humans
  38. Kanayama G, Amiaz R, Seidman S, Pope HG. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol. 2007 Dec; 15(6):529-38. PMID: 18179305.
    Citations: 8     Fields:    Translation:HumansAnimals
  39. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007 May 11; 88(2-3):156-62. PMID: 17127018.
    Citations: 25     Fields:    Translation:Humans
  40. Kanayama G, Barry S, Hudson JI, Pope HG. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006 Apr; 163(4):697-703. PMID: 16585446.
    Citations: 23     Fields:    Translation:Humans
  41. Pillay SS, Rogowska J, Kanayama G, Jon DI, Gruber S, Simpson N, Cherayil M, Pope HG, Yurgelun-Todd DA. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend. 2004 Dec 07; 76(3):261-71. PMID: 15561477.
    Citations: 12     Fields:    Translation:Humans
  42. Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users' attitudes towards physicians. Addiction. 2004 Sep; 99(9):1189-94. PMID: 15317640.
    Citations: 21     Fields:    Translation:Humans
  43. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004 Nov; 176(3-4):239-47. PMID: 15205869.
    Citations: 68     Fields:    Translation:HumansCTClinical Trials
  44. Kanayama G, Pope HG, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003 Jul 20; 71(1):77-86. PMID: 12821208.
    Citations: 30     Fields:    Translation:Humans
  45. Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003 Feb; 64(2):156-60. PMID: 12633124.
    Citations: 25     Fields:    Translation:Humans
  46. Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Jan; 160(1):105-11. PMID: 12505808.
    Citations: 54     Fields:    Translation:HumansCTClinical Trials
  47. Negus SS, Pope HG, Kanayama G, Wines JD, Fischer BD. Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology. 2001 Nov; 26(8):789-96. PMID: 11585679.
    Citations: 5     Fields:    Translation:Animals
  48. Kanayama G, Gruber AJ, Pope HG, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001 May-Jun; 70(3):137-40. PMID: 11340414.
    Citations: 23     Fields:    Translation:Humans
  49. Kanayama G, Pope HG, Hudson JI. "Body image" drugs: a growing psychosomatic problem. Psychother Psychosom. 2001 Mar-Apr; 70(2):61-5. PMID: 11244386.
    Citations: 14     Fields:    Translation:Humans
  50. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2000 Sep; 2(3 Pt 2):237-48. PMID: 11249801.
    Citations: 85     Fields:    Translation:Humans
  51. Kanayama G, Takeda M, Morihara T, Miyamae Y, Shinozaki K, Nishikawa T, Niigawa H, Nishimura T. Temporal and regional profiles of cytoskeletal protein accumulation in the rat brain following traumatic brain injury. Psychiatry Clin Neurosci. 1997 Jun; 51(3):157-65. PMID: 9225381.
    Citations: 1     Fields:    Translation:AnimalsCells
  52. Kanayama G, Takeda M, Niigawa H, Ikura Y, Tamii H, Taniguchi N, Kudo T, Miyamae Y, Morihara T, Nishimura T. The effects of repetitive mild brain injury on cytoskeletal protein and behavior. Methods Find Exp Clin Pharmacol. 1996 Mar; 18(2):105-15. PMID: 8740242.
    Citations: 13     Fields:    Translation:AnimalsCells
  53. Tatebayashi Y, Takeda M, Kashiwagi Y, Okochi M, Kurumadani T, Sekiyama A, Kanayama G, Hariguchi S, Nishimura T. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia. 1995 Jan-Feb; 6(1):9-16. PMID: 7728221.
    Citations: 7     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kanayama's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (248)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.